Polyganics

Groningen, Netherlands Founded: 1999 • Age: 27 yrs Acquired By Collagen Matrix
Bioresorbable medical devices are developed for tissue repair and regeneration.
Request Access

About Polyganics

Polyganics is a company based in Groningen (Netherlands) founded in 1999 was acquired by Collagen Matrix in October 2022.. Polyganics offers products and services including RejuvaKnee™, Collagen Dental Membrane, and Dural Repair Products. Polyganics operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Groningen, Netherlands
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Collagen Matrix Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.3 M (USD), Grant

    May 13, 2020

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Collagen Matrix

    (Oct 05, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Polyganics

Polyganics offers a comprehensive portfolio of products and services, including RejuvaKnee™, Collagen Dental Membrane, and Dural Repair Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

FDA-cleared device for meniscal repair and tissue regeneration.

Material for dental tissue healing and surgical support.

Bioresorbable solutions for dural closure in neurosurgery.

People of Polyganics
Headcount 10-50
Employee Profiles 12
Board Members and Advisors 3
Employee Profiles
People
Betty Ijmker
Director Quality Assurance & Regulatory Affairs
People
noah meurs
Technician II Operations
People
Alexander Jantjes
Manufacturing Engineer
People
Harm de Vries
Director Operations

Unlock access to complete

Board Members and Advisors
people
Ralph Voncken
Chairman
people
Annemieke Wouterse
Director
people
Jan Öhrström
Director

Unlock access to complete

Funding Insights of Polyganics

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $1.3M
  • First Round

    (01 Dec 2017)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2020 Amount Grant - Polyganics Valuation

investors

SNN
Apr, 2019 Amount Grant - Polyganics Valuation

investors

Dec, 2017 Amount Grant - Polyganics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Polyganics

Polyganics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Commission, Collagen Matrix and SNN. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Financial support is provided for regional development in Northern Netherlands.
Founded Year Domain Location
Institution of the European Union responsible for upholding the EU treaties
Founded Year Domain Location
Collagen and mineral based medical devices
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Polyganics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Polyganics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Polyganics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Polyganics

Polyganics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of pharmaceuticals and vaccines for various therapeutic areas
domain founded_year HQ Location
Antibody-siRNA complexes are developed for cancer treatment.
domain founded_year HQ Location
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
domain founded_year HQ Location
Yeast cells are genetically engineered to produce medicinal products.
domain founded_year HQ Location
Developing novel drugs based on a proteome-wide ligand and target discovery platform
domain founded_year HQ Location
CRISPR-engineered cell and gene therapies are developed for research applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Polyganics

Frequently Asked Questions about Polyganics

When was Polyganics founded?

Polyganics was founded in 1999 and raised its 1st funding round 18 years after it was founded.

Where is Polyganics located?

Polyganics is headquartered in Groningen, Netherlands. It is registered at Groningen, Groningen, Netherlands.

What does Polyganics do?

Polyganics is a medical technology company developing bioresorbable medical devices that facilitate natural tissue repair and regeneration based on their proprietary polymer technology. The companys platform allows the integration of polymer chemistry and engineering design to enable development of medical products with specific features such as porous scaffolds, tubes, sheets, sleeves or foams with tailor-made properties. The companys current product range covers ENT products, peripheral nerve repair and neurosurgery products and general surgery products. In 2014, Polyganics divested its ENT portfolio to Stryker.

Who are the top competitors of Polyganics?

Polyganics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

What products or services does Polyganics offer?

Polyganics offers RejuvaKnee™, Collagen Dental Membrane, and Dural Repair Products.

Who are Polyganics's investors?

Polyganics has 3 investors. Key investors include European Commission, Collagen Matrix, and SNN.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available